Enrollment open: 1,500 original practice questions built on NABP’s official MPJE Competency Statements. Enroll today and start with the free sample exam.
The Delaware MPJE — the Multistate Pharmacy Jurisprudence Examination as administered for Delaware licensure — tests federal pharmacy law and Delaware pharmacy law in a single sitting, with no distinction between them: where the Delaware rule and the federal rule differ, the Delaware rule is the one the question is answered under. PassProfessor’s Delaware MPJE program prepares you with 1,500 original practice questions built exactly that way — an 800-question federal core intermixed with 700 Delaware-specific questions grounded in the Delaware Pharmacy Act, the Board of Pharmacy regulations, the Uniform Controlled Substances Act, its prescription monitoring program law and its substitution law — weighted to NABP’s current Competency Statements.
What the program covers
Every competency area on NABP’s current MPJE Competency Statements is covered at its published weight. The bank’s question count in each area, and what a full practice exam draws from each:
- Licensure and Personnel — 333 practice questions; 22 per full practice exam
- Pharmacist Practice — 498 practice questions; 33 per full practice exam
- Dispensing Requirements — 358 practice questions; 24 per full practice exam
- Pharmacy Operations — 311 practice questions; 21 per full practice exam
A full practice exam draws 100 scored questions — the scored length of the real exam — across all four competency areas at their published weights, inside a 150-minute limit that mirrors the real 2.5-hour clock. The real exam administers 120 questions: the same 100 scored questions plus 20 unscored pretest questions mixed in; this program’s draws are scored questions only. Practice exams are scored against a 70% practice benchmark: the real MPJE is pass/fail and NABP does not publish a raw passing score, so treat the benchmark as a practice target, not an NABP standard.
How the program works
Enroll once and the full course opens: full-length practice exams, a free 20-question sample to start with, and per-topic drills for focused work on the competency areas you want to strengthen. Every practice exam draws a fresh set of questions, so repeat attempts keep testing rather than repeating. Every question in the program includes an explanation of why the keyed answer is right.
Delaware MPJE at a glance
- Questions on the real exam: 120 administered (100 scored + 20 unscored pretest)
- Time limit: 2.5 hours
- Format: computer-based at Pearson VUE; federal and Delaware questions intermixed, with no distinction between them
- Scoring: pass/fail — NABP does not publish a raw passing score
- Attempts: up to 5 per jurisdiction
- Fees: about $270 per attempt in NABP fees
- Eligibility: confirmed by the Delaware Board of Pharmacy
- Score transfer: MPJE scores are not transferable between jurisdictions — a Delaware pass applies to Delaware licensure
The Delaware law behind the exam
Half of what makes the Delaware MPJE hard is that it is two bodies of law at once. The Delaware half of this program is built on:
- The Delaware questions in this bank are grounded in primary Delaware sources read first-hand: the Pharmacy Act (Title 24 of the Delaware Code, Chapter 25), the Board of Pharmacy regulations (Title 24 of the Delaware Administrative Code, section 2500), the Uniform Controlled Substances Act (Title 16, Chapter 47) and its regulations in Title 24 of the Administrative Code, the prescription monitoring law inside that Act, the generic and biologic substitution law in Chapter 25, the pharmacist contraception law (Title 16, Chapter 30O) and the Opioid Antagonist Access Program law (Title 16, Chapter 30G). Delaware pharmacy law was comprehensively amended effective June 30, 2026, and this bank keys on the amended text — including the discipline law as it now stands.
- Delaware’s prescription monitoring program is established inside the Uniform Controlled Substances Act and run by the Office of Controlled Substances; dispensers report Schedule II–V dispensing — and any drug of concern designated by regulation — on the schedule the Office sets by regulation. The check duty is belief-triggered, not universal: a dispenser or prescriber who reasonably believes a patient may be seeking a Schedule II–V substance for a reason other than treatment of an existing medical condition must pull the patient’s utilization report for the preceding 12 months before dispensing or prescribing. Unlawful disclosure of program information is a felony, and a prescriber holding a Delaware controlled-substance registration must register with the program within 90 days of obtaining that registration.
- Delaware substitution is permissive and opt-in. A pharmacist may dispense a therapeutically equivalent, lower-priced product only when the prescriber has signed the ‘Substitution Permitted’ line on a written prescription or stated that substitution may be made on a verbal one; the brand product is dispensed when the prescriber handwrites ‘Brand Necessary’ or ‘Brand Medically Necessary,’ and the patient is told whenever a product selection is made. There is no mandatory-substitution rule and no pass-on-the-savings rule. For an interchangeable biologic, the prescriber must be told the product dispensed and its manufacturer within 10 days, unless no interchangeable product exists or the refill is the same product. Delaware also schedules its own way: buprenorphine is Schedule V in Delaware though federal law places it in Schedule III, cannabis remains textually in Schedule I while an adult’s personal-use quantity carries no penalty, and the Secretary may follow a federal scheduling change only when both statutory conditions are met — conformity is never automatic.
- The people rules run on even-year cycles: pharmacist licenses and pharmacy permits expire September 30 of even years, with a 60-day late-renewal window, and pharmacists complete 30 hours of continuing education per biennium — including at least 2 hours on medication safety and errors and 2 hours on controlled substances and impairment — with no carryover. Internship is 1,500 hours, at least 1,000 of them in community or hospital practice. Delaware does not license or register pharmacy technicians and sets no numeric pharmacist-to-technician ratio: a technician’s standing rests on national certification and employer training completed within 90 days, and only certified technicians may reconstitute oral solutions, contact prescribers about refill authorization, assist with compounding, or give adult immunizations. Every pharmacy has exactly one pharmacist-in-charge, who serves only that one pharmacy and completes a self-inspection by February 1 each year.
- At the counter, three Delaware rules draw questions every cycle: a practitioner dispensing controlled substances to their own patients is capped at a 72-hour supply — pharmacies are expressly excepted; the opioid safe-prescribing limits (a first outpatient opioid for acute pain capped at a 7-day supply, and no opioid for a minor above a 7-day supply) bind prescribers, not pharmacists; and immunizations may be given from age 3 under a prescriber’s order or protocol, with every administration reported to the state registry, DelVAX, within 72 hours. Discipline runs on the current amended text: individual sanctions reach a $10,000 fine for a first violation and $50,000 per subsequent violation, with permanent revocation available — and a pharmacist who dispenses naloxone in good faith under the state’s access program is protected from discipline and liability absent a failure of reasonable care or gross negligence.
What changes on March 1, 2027
- From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline — Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, Pharmacy Operations 20%.
- Every question in this bank is dual-tagged to both blueprints, so this program’s practice exams re-weight to the new outline when the change takes effect — the questions you are practicing now stay the right questions.
Three things worth knowing
- One scoring point to be clear about: the 70% figure used inside this program is a practice benchmark only. The real MPJE is pass/fail against a standard NABP does not publish as a raw score, and no percentage — ours or anyone else’s — is the MPJE passing standard.
- One portability point: MPJE scores are not transferable. (Score transfer belongs to the separate uniform UMPJE, used in 13 other jurisdictions.) This program prepares you for the Delaware MPJE specifically.
- One scope point: the 800-question federal core is the same law every MPJE state tests, but the 700 Delaware questions key on Delaware law. If you later seek licensure in another MPJE state, you will need that state’s law exam preparation, not Delaware’s.
For the detailed walk-through of the exam’s format, scoring and rules, read the Delaware MPJE Exam Guide.
